Overview of hepatitis B virus mutations and their implications in the management of infection

doi:10.3748/wjg.v22.i1.145

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15276)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

1187

WORD

472

HTML

9082

Tables (1-2)

315

Sum=11056

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

498

Download

741

Sum=1239

Publishing Process of This Article

Item

Count

Browse

1506

Download

1475

Sum=2981

Jan 7, 2016 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (116)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 7, 2016; 22(1): 145-154
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.145

Table 1 Cross-resistance data for the most frequent resistant hepatitis B virus variant

HBV variants	Level of susceptibility
HBV variants	Lamivudine	Telbivudine	Entecavir	Adefovir	Tenofovir
Wild-tipe	S	S	S	S	S
M204V	R	S	I	I	S
M204I	R	R	I	I	S
L180M + M204V	R	R	I	I	S
A181A/T	I	S	S	R	S
N236T	S	S	S	R	I
L180M + M204V/I ± I196T ± V173L ± M250V	R	R	R	S	S
L180M + M204V/I ± T184G ± S202I/G	R	R	R	S	S

The amino-acid substitution profiles are shown in the left column and the level or susceptibility is given for each drugs: S (sensitive), I (intermediate/reduced susceptibility), R (resistant). EASL Clinical Practice Guidelines 2012.

Citation: Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 2016; 22(1): 145-154
URL: https://www.wjgnet.com/1007-9327/full/v22/i1/145.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i1.145